• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER, INC. (IRWINDALE) NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER, INC. (IRWINDALE) NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number D-1266-01-S
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Infarction, Cerebral (1771); Low Blood Pressure/ Hypotension (1914); Ambulation Difficulties (2544)
Event Date 03/23/2017
Event Type  Injury  
Manufacturer Narrative
The product was discarded, therefore no product failure analysis can be conducted and device malfunction cannot be confirmed.Since no lot number was provided, no device history record (dhr) review could be performed.Concomitant products: mullins long transseptal sheath.(b)(4).
 
Event Description
It was reported that a (b)(6) male patient underwent an ablation procedure for non-ischemic ventricular tachycardia with a navistar rmt thermocool catheter and suffered bilateral thalamic infarcts requiring multiple computed tomography (ct) scans and magnetic resonance imaging (mri).At the conclusion of the procedure, the patient did not awaken as expected.Neurological testing was performed, as a procedure-related neurological event was suspected.Initially, computed tomography (ct) ruled out an embolic stroke.Patient was reported to be in stable condition.Later cts and an mri revealed bilateral thalamic infarcts.No new medications were administered.Patient required extended hospitalization as a result of the adverse event for neurological testing.Patient was discharged with memory intact and a normal cognitive state.Patient currently has an abnormal gait and impaired level of alertness.Patient will attend physical rehabilitation for up to 6 months.Physician¿s initial opinion regarding the cause of the adverse event was that it was procedure-related.After conferring with other electrophysiologists and a neurologist, the physician believes that the patient¿s pre-procedure hypertension followed by the anesthetic technique of maintaining a relatively hypotensive state during the procedure, was likely the cause.It was also noted that there was speculation that tiny microbubbles may have contributed to the multiple areas of infarct.The sheath in use during the event was a mullins long transseptal sheath.
 
Manufacturer Narrative
On 10/16/2017, the 6-month patient status follow up was completed.The patient was discharged from the hospital after the event with a few new medications (anti-lipid, unspecified).The neurology team was not convinced that the event was a result of hypoperfusion, and that bilateral embolic strokes were a possibility.The patient still has cognitive deficiencies, and though most abilities are intact, there is short term memory loss and attentional difficulties.These issues have improved, and should continue to improve per the neurologists.However, the patient is on disability and can no longer work.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BIOSENSE WEBSTER, INC. (IRWINDALE)
15715 arrow highway
irwindale CA 91706
Manufacturer (Section G)
BIOSENSE WEBSTER, INC. (IRWINDALE)
15715 arrow highway
irwindale CA 91706
Manufacturer Contact
joaquin kurz
33 technology drive
irvine, CA 92618
9497893837
MDR Report Key6490513
MDR Text Key72743756
Report Number2029046-2017-00120
Device Sequence Number1
Product Code OAD
Combination Product (y/n)N
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD-1266-01-S
Device Catalogue NumberNR7TCSIY
Device Lot NumberUNKNOWN_D-1266-01-S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/24/2017
Initial Date FDA Received04/13/2017
Supplement Dates Manufacturer Received03/24/2017
Supplement Dates FDA Received10/23/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening;
Patient Age56 YR
-
-